President Trump has promised answers soon on a potential shift in national drug policy. Last year, the Biden administration proposed moving marijuana from the DEA's Schedule 1 to Schedule 3, which wouldn’t make it legal on the federal level but would ease federal restrictions. John Yang discussed what that long-anticipated change could mean with Beau Kilmer of RAND's Drug Policy Research Center.

See Full Page